NCI/FDA Task Force Will Serve As Resource During Approval Process

NCI-funded investigators who reach an impasse in the regulatory process can utilize the "leadership group" of the FDA/NCI Interagency Oncology Task Force. The task force is converting its work into FDA guidance documents.